Posted in | News | Mining Business | Potash

Tri-River Ventures Signs Share Acquisition Agreement to Buy Taiji Resources

Tri-River Ventures Inc. (TSX.V Symbol: TVR.V) announces that it has entered into a share acquisition agreement with Strong Rising International Limited, to acquire a 100% interest in Strong Rising's wholly owned subsidiary Taiji Resources Ltd.

Taiji is a private resources exploration company registered in the Province of Saskatchewan.  In consideration of the acquisition, the Company will issue common shares to Taiji's shareholder, which will be determined following completion of the Company's ongoing due diligence work. The acquisition is subject to shareholder approvals and TSX Venture Exchange acceptance.

Taiji holds a 100% interest in three non-contiguous potash exploration permits in the Province of Saskatchewan.  The three separate permits, KP460, KP461, and KP465 (the "Permits") are favorably located in southern Saskatchewan and are at the preliminary exploration stage. Permit KP460, consisting of 18,479 acres, is approximately 160 kilometers east of Regina on the TransCanada Highway. Permit KP 461, consisting of 32,583 acres is approximately 40 kilometers west of Regina near Moose Jaw, and Permit KP 465, consisting of 12,464 acres is approximately 55 kilometers northeast from Saskatoon. The Permits cover a total 1026 square kilometers. A sequence of Mid Devonian carbonates and evaporites containing the target strata of interest for potash is projected to pass under all three Permits. 2D seismic geophysical test reports have been received on KP461 and KP460 consistent with this conclusion.

Source: Tri-River Ventures Inc.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.